Investigating the low vulnerability of posterior eye segment to SARS-CoV-2
Steffen E. Künzel, MD, discusses the key points of his research presentation regarding low vulnerability of the posterior eye segment to SARS-CoV-2 infection.
Steffen E. Künzel, MD, from the Department of Ophthalmology Charité University Medicine Berlin, Berlin, Germany, discusses the key points of his research presentation on low vulnerability of the posterior eye segment to SARS-CoV-2 infection during the virtual 2021 ARVO meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Articles
- The European Commission grants marketing authorization for EYLUXVI
September 23rd 2025
- Luxa Biotechnology announces clinical trial results for treatment of AMD
September 22nd 2025
- Q&A: Anat Loewenstein recaps the 2025 EURETINA meeting
September 22nd 2025
- Justis P. Ehlers, MD, on the HELIOS trial for NPDR
September 21st 2025